person · Reporting owner
Lakkaraju Roop Kalyan
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BENCHMARK ELECTRONICS INCBHE · Entity 4343 | EVP, Chief Financial Officer | February 23, 2024 | February 28, 2024 |
| BIO-RAD LABORATORIES, INC.BIO BIO.B · Entity 2247 | EVP, Chief Financial Officer | September 04, 2026 | September 09, 2026 |
| Support.com, Inc.SPRT · Entity 135472 | EVP, CFO & COO | November 14, 2016 | November 15, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BENCHMARK ELECTRONICS INC
Report date February 23, 2024 · Filed February 28, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 150,716 |
Ending reported balance
After 2024-02-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-02-23 · Tax withholding · Disposed 3,219 · Balance 153,517 F1: These shares are being withheld to cover taxes related to the vesting of restricted stock units. Row 2 · 2024-02-26 · Tax withholding · Disposed 2,801 · Balance 150,716 F1: These shares are being withheld to cover taxes related to the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are being withheld to cover taxes related to the vesting of restricted stock units.
BIO-RAD LABORATORIES, INC.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 3,955.963 |
Reported balance
After 2026-09-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-05 · Exercise / conversion · Acquired 1,370 · Balance 3,955.963 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. F2: Includes 22.0680 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2026. |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 3,396.963 |
Reported balance
After 2026-09-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-05 · Tax withholding · Disposed 559 · Balance 3,396.963 |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 4,932.963 |
Reported balance
After 2026-09-06 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-09-06 · Exercise / conversion · Acquired 1,536 · Balance 4,932.963 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 4,150.963 |
Reported balance
After 2026-09-06 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-09-06 · Tax withholding · Disposed 782 · Balance 4,150.963 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 6,326 |
Reported balance
After 2026-09-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-04 · Grant · Acquired 6,326 · Balance 6,326 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,110 |
Reported balance
After 2026-09-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-05 · Exercise / conversion · Disposed 1,370 · Balance 4,110 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,072 |
Reported balance
After 2026-09-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-06 · Exercise / conversion · Disposed 1,536 · Balance 3,072 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 22.0680 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2026.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Support.com, Inc.
Report date November 14, 2016 · Filed November 15, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,159 |
Reported balance
After 2016-11-14 transaction · row 1
1 source rowRow 1 · 2016-11-14 · Purchase · Acquired 1,000 · Balance 144,159 F1: The reporting person is reporting the acquisition of shares of the issuer's 2011 Employee Stock Purchase Plan ("ESPP"), elected for purchase prior to the ESPP purchase period of May 15, 2016 to November 14, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the acquisition of shares of the issuer's 2011 Employee Stock Purchase Plan ("ESPP"), elected for purchase prior to the ESPP purchase period of May 15, 2016 to November 14, 2016.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Infinera Corp
Report date February 28, 2025 · Filed March 03, 2025
Section 16 reporting ended · disclosed 2025-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-02-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-02-28 · Exercise / conversion · Acquired 36,697 · Balance 130,851 Row 2 · 2025-02-28 · Disposition to issuer · Disposed 130,851 · Balance 0 F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 27, 2024, by and among Nokia Corporation, Neptune of America Corporation and Infinera Corporation ("Company"), referred to as the "Merger Agreement". F2: Each share of Company common stock held by the Reporting Person was automatically cancelled, extinguished and converted into the right to receive the consideration provided in the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-02-28 · Exercise / conversion · Disposed 36,697 · Balance 0 F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock. F4: Immediately prior to the Effective Time (as defined in the Merger Agreement) of the merger, each share of Company common stock underlying this unvested RSU award originally granted to Reporting Person on June 12, 2024, fully vested and converted automatically into the right to receive the consideration provided in the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 27, 2024, by and among Nokia Corporation, Neptune of America Corporation and Infinera Corporation ("Company"), referred to as the "Merger Agreement".
F2: Each share of Company common stock held by the Reporting Person was automatically cancelled, extinguished and converted into the right to receive the consideration provided in the Merger Agreement.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F4: Immediately prior to the Effective Time (as defined in the Merger Agreement) of the merger, each share of Company common stock underlying this unvested RSU award originally granted to Reporting Person on June 12, 2024, fully vested and converted automatically into the right to receive the consideration provided in the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,536 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · derivative · entry 7 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,072 Underlying: Bio-Rad A Common Stock · 1,536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 782 | $386.11 | $301,938.02 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 4 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,150.963 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,932.963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,370 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · derivative · entry 6 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 1,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 559 | $386.11 | $215,835.49 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,396.963 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,955.963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 22.0680 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2026. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 6,326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · derivative · entry 5 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,326 Underlying: Bio-Rad A Common Stock · 6,326 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:21 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,078 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000002 · wk-form4_1777393306.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,156 Underlying: Bio-Rad A Common Stock · 1,078 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:21 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 420 | $287.84 | $120,892.80 |
DisclosureSEC source: 0001396867-26-000002 · wk-form4_1777393306.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,563.895 Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 16:21 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000002 · wk-form4_1777393306.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,983.895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 62.2360 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,535 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · derivative · entry 4 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,608 Underlying: Bio-Rad A Common Stock · 1,535 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 550 | $295.43 | $162,486.50 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,843.659 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,393.659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 13.2750 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2025. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:23 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 5,480 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-25-000004 · wk-form4_1757449415.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,480 Underlying: Bio-Rad A Common Stock · 5,480 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,077 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-008078 · form4.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,234 Underlying: Bio-Rad A Common Stock · 1,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 386 | $249.74 | $96,399.64 |
DisclosureSEC source: 0001062993-25-008078 · form4.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845.384 Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 22:07 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-008078 · form4.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,231.384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 66.8810 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:59 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,891 | $0.00 Strike: $256.45 | $0.00 |
DisclosureSEC source: 0001062993-25-004603 · form4.xml · derivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,891 Underlying: Bio-Rad A Common Stock · 3,891 shares Expires 2035-03-03 F2 · derivative.exercise_date: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 16:36 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 36,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-25-000053 · wk-form4_1741037807.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,697 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: Immediately prior to the Effective Time (as defined in the Merger Agreement) of the merger, each share of Company common stock underlying this unvested RSU award originally granted to Reporting Person on June 12, 2024, fully vested and converted automatically into the right to receive the consideration provided in the Merger Agreement. F4 · derivative.expiration_date: Immediately prior to the Effective Time (as defined in the Merger Agreement) of the merger, each share of Company common stock underlying this unvested RSU award originally granted to Reporting Person on June 12, 2024, fully vested and converted automatically into the right to receive the consideration provided in the Merger Agreement. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 16:36 UTC | Infinera Corp INFN · Entity 82602 | Disposition to issuerCommon Stock | 130,851 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001138639-25-000053 · wk-form4_1741037807.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 27, 2024, by and among Nokia Corporation, Neptune of America Corporation and Infinera Corporation ("Company"), referred to as the "Merger Agreement". F2 · price: Each share of Company common stock held by the Reporting Person was automatically cancelled, extinguished and converted into the right to receive the consideration provided in the Merger Agreement. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 16:36 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 36,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-25-000053 · wk-form4_1741037807.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2025 Filed Feb 18, 2025 17:53 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 6,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-25-000027 · wk-form4_1739919223.xml · derivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,478 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company") F2 · derivative.exercise_date: These RSUs vest in three annual installments beginning on the one-year anniversary of the vesting commencement date, which is February 16, 2022, subject to Mr. Lakkaraju's continued service to the Company. F2 · derivative.expiration_date: These RSUs vest in three annual installments beginning on the one-year anniversary of the vesting commencement date, which is February 16, 2022, subject to Mr. Lakkaraju's continued service to the Company. Read SEC document |
| February 16, 2025 Filed Feb 18, 2025 17:53 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 6,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-25-000027 · wk-form4_1739919223.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 6,143 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016394 · form4.xml · derivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,143 Underlying: Bio-Rad A Common Stock · 6,143 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 17:34 UTC | Infinera Corp INFN · Entity 82602 | GrantRestricted Stock Units · Derivative | 36,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-24-000184 · wk-form4_1718400854.xml · derivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,697 Underlying: Common Stock · 36,697 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F2 · derivative.exercise_date: These RSUs vest on the earlier of (i) the date of the Company's 2025 annual meeting of stockholders, provided that such annual meeting of stockholders occurs at least 50 weeks after the date of the Company's 2024 annual meeting of stockholders which was held on June 12, 2024, or (ii) the one-year anniversary of the June 12, 2024 date of grant, subject in each case to Mr. Lakkaraju's continued service to the Company. F2 · derivative.expiration_date: These RSUs vest on the earlier of (i) the date of the Company's 2025 annual meeting of stockholders, provided that such annual meeting of stockholders occurs at least 50 weeks after the date of the Company's 2024 annual meeting of stockholders which was held on June 12, 2024, or (ii) the one-year anniversary of the June 12, 2024 date of grant, subject in each case to Mr. Lakkaraju's continued service to the Company. Read SEC document |
| May 18, 2024 Filed May 21, 2024 19:19 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock · Derivative | 39,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-24-000143 · wk-form4_1716333557.xml · derivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company") F2 · derivative.exercise_date: These RSUs have a vesting commencement date of May 18, 2023 and vest on the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the date of grant, subject to Mr. Lakkaraju's continued service to the Company. F2 · derivative.expiration_date: These RSUs have a vesting commencement date of May 18, 2023 and vest on the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the date of grant, subject to Mr. Lakkaraju's continued service to the Company. Read SEC document |
| May 18, 2024 Filed May 21, 2024 19:19 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 39,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-24-000143 · wk-form4_1716333557.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2024 Filed Apr 29, 2024 22:17 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 4,311 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009019 · form4.xml · derivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,311 Underlying: Bio-Rad A Common Stock · 4,311 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 00:23 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Tax withholdingCommon Stock | 2,801 | $29.97 | $83,945.97 |
DisclosureSEC source: 0000950170-24-021540 · ownership.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,716 F1 · shares: These shares are being withheld to cover taxes related to the vesting of restricted stock units. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 00:23 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Tax withholdingCommon Stock | 3,219 | $29.73 | $95,700.87 |
DisclosureSEC source: 0000950170-24-021540 · ownership.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,517 F1 · shares: These shares are being withheld to cover taxes related to the vesting of restricted stock units. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 01:37 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | GrantPerformance-Based Restricted Stock Units · Derivative | 25,321 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-020510 · ownership.xml · derivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,321 Underlying: Common Stock · 25,321 shares Expires 2027-03-15 F2 · shares: This reflects the target number of performance-based restricted stock units awarded. Actual awards may vary from as low as zero to as high as 2.5 times the target. As soon as reasonably practicable following the end of the Performance Period (beginning on January 1, 2024 and ending on December 31, 2026) and in no event later than March 15, 2027, the number of shares that may ultimately be earned will be determined and issued. F2 · derivative.exercise_date: This reflects the target number of performance-based restricted stock units awarded. Actual awards may vary from as low as zero to as high as 2.5 times the target. As soon as reasonably practicable following the end of the Performance Period (beginning on January 1, 2024 and ending on December 31, 2026) and in no event later than March 15, 2027, the number of shares that may ultimately be earned will be determined and issued. F2 · derivative.expiration_date: This reflects the target number of performance-based restricted stock units awarded. Actual awards may vary from as low as zero to as high as 2.5 times the target. As soon as reasonably practicable following the end of the Performance Period (beginning on January 1, 2024 and ending on December 31, 2026) and in no event later than March 15, 2027, the number of shares that may ultimately be earned will be determined and issued. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 01:37 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | GrantCommon Stock | 25,321 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-020510 · ownership.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,736 F1 · shares: These shares are represented by a restricted stock unit award bearing the right to receive Common Shares and are scheduled to vest in ratable annual installments over a three-year period from the grant date. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 02:33 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Exercise / conversionPerformance-based Restricted Stock Units · Derivative | 19,516 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-019089 · ownership.xml · derivative · entry 4 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,516 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Based on the Company performance during the three-year performance period ending December 31, 2023, approximately 111.63% of the performance-based restricted stock units vested (as previously disclosed, the reporting person had the opportunity to earn up to 250% of the number originally reported) F1 · derivative.expiration_date: Based on the Company performance during the three-year performance period ending December 31, 2023, approximately 111.63% of the performance-based restricted stock units vested (as previously disclosed, the reporting person had the opportunity to earn up to 250% of the number originally reported) Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 02:33 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | GrantPerformance-based Restricted Stock Units · Derivative | 2,033 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-019089 · ownership.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,516 Underlying: Common Stock · 2,033 shares Expires 2023-12-31 F1 · derivative.exercise_date: Based on the Company performance during the three-year performance period ending December 31, 2023, approximately 111.63% of the performance-based restricted stock units vested (as previously disclosed, the reporting person had the opportunity to earn up to 250% of the number originally reported) F1 · derivative.expiration_date: Based on the Company performance during the three-year performance period ending December 31, 2023, approximately 111.63% of the performance-based restricted stock units vested (as previously disclosed, the reporting person had the opportunity to earn up to 250% of the number originally reported) Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 02:33 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Tax withholdingCommon Stock | 13,318 | $29.22 | $389,151.96 |
DisclosureSEC source: 0000950170-24-019089 · ownership.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,415 F2 · shares: These shares are being withheld to cover taxes related to the vesting of restricted stock units. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 02:33 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Exercise / conversionCommon Stock | 19,516 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-019089 · ownership.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Based on the Company performance during the three-year performance period ending December 31, 2023, approximately 111.63% of the performance-based restricted stock units vested (as previously disclosed, the reporting person had the opportunity to earn up to 250% of the number originally reported) Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 18:22 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 6,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-24-000020 · wk-form4_1708125751.xml · derivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,478 Underlying: Common Stock · 6,478 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company") F2 · derivative.exercise_date: These RSUs vest in three annual installments beginning on the one-year anniversary of the vesting commencement date, which is February 16, 2022, subject to Mr. Lakkaraju's continued service to the Company. F2 · derivative.expiration_date: These RSUs vest in three annual installments beginning on the one-year anniversary of the vesting commencement date, which is February 16, 2022, subject to Mr. Lakkaraju's continued service to the Company. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 18:22 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 6,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-24-000020 · wk-form4_1708125751.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2023 Filed May 19, 2023 18:17 UTC | Infinera Corp INFN · Entity 82602 | GrantRestricted Stock Units · Derivative | 39,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-23-000102 · wf-form4_168453464056724.xml · derivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,447 Underlying: Common Stock · 39,447 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F3 · derivative.exercise_date: These RSUs have a vesting commencement date of May 18, 2023 and vest on the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the date of grant, subject to Mr. Lakkaraju's continued service to the Company. F3 · derivative.expiration_date: These RSUs have a vesting commencement date of May 18, 2023 and vest on the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the date of grant, subject to Mr. Lakkaraju's continued service to the Company. Read SEC document |
| May 18, 2023 Filed May 19, 2023 18:17 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 35,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-23-000102 · wf-form4_168453464056724.xml · derivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F2 · derivative.exercise_date: These RSUs have a vesting commencement date of May 19, 2022 and vest on the earlier of the date of the next annual meeting or stockholders or the one-year anniversary of the date of grant, subject to Mr. Lakkaraju's continued service to the Company. F2 · derivative.expiration_date: These RSUs have a vesting commencement date of May 19, 2022 and vest on the earlier of the date of the next annual meeting or stockholders or the one-year anniversary of the date of grant, subject to Mr. Lakkaraju's continued service to the Company. Read SEC document |
| May 18, 2023 Filed May 19, 2023 18:17 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 35,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-23-000102 · wf-form4_168453464056724.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:34 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Tax withholdingCommon Stock | 2,801 | $23.74 | $66,495.74 |
DisclosureSEC source: 0001209191-23-014130 · doc4.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,217 F1 · shares: These shares are being withheld to cover taxes related to the vesting of restricted stock units. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 02:42 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | GrantPerformance-based Restricted Stock Units · Derivative | 27,653 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013498 · doc4.xml · derivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,653 Underlying: Common Stock · 27,653 shares Expires not disclosed F2 · shares: This reflects the target number of performance-based restricted stock units awarded. Actual awards may vary from as low as zero to as high as 2.5 times the target. As soon as reasonably practicable following the end of the Performance Period (beginning on January 1, 2023 and ending on December 31, 2025) and in no event later than March 15, 2026, the number of shares that may ultimately be earned will be determined and issued. F2 · derivative.exercise_date: This reflects the target number of performance-based restricted stock units awarded. Actual awards may vary from as low as zero to as high as 2.5 times the target. As soon as reasonably practicable following the end of the Performance Period (beginning on January 1, 2023 and ending on December 31, 2025) and in no event later than March 15, 2026, the number of shares that may ultimately be earned will be determined and issued. F2 · derivative.expiration_date: This reflects the target number of performance-based restricted stock units awarded. Actual awards may vary from as low as zero to as high as 2.5 times the target. As soon as reasonably practicable following the end of the Performance Period (beginning on January 1, 2023 and ending on December 31, 2025) and in no event later than March 15, 2026, the number of shares that may ultimately be earned will be determined and issued. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 02:42 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | GrantCommon Stock | 27,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013498 · doc4.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,018 F1 · shares: These shares are represented by a restricted stock unit award bearing the right to receive Common Shares and are scheduled to vest in ratable annual installments over a four-year period from the grant date. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:06 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Exercise / conversionPerformance-based Restricted Stock Units · Derivative | 14,573 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013009 · doc4.xml · derivative · entry 7 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Based on the Company performance during the two-year performance period ending December 31, 2022, approximately 166.7% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). F2 · derivative.expiration_date: Based on the Company performance during the two-year performance period ending December 31, 2022, approximately 166.7% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:06 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | GrantPerformance-based Restricted Stock Units · Derivative | 5,831 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013009 · doc4.xml · derivative · entry 6 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,573 Underlying: Common Stock · 5,831 shares Expires not disclosed F2 · derivative.exercise_date: Based on the Company performance during the two-year performance period ending December 31, 2022, approximately 166.7% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). F2 · derivative.expiration_date: Based on the Company performance during the two-year performance period ending December 31, 2022, approximately 166.7% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:06 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Disposition to issuerPerformance-based Restricted Stock Units · Derivative | 3,830 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013009 · doc4.xml · derivative · entry 5 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,830 shares Expires not disclosed F1 · derivative.exercise_date: Based on the Company performance during the three-year performance period ending December 31, 2022, approximately 78.5% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). F1 · derivative.expiration_date: Based on the Company performance during the three-year performance period ending December 31, 2022, approximately 78.5% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:06 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Exercise / conversionPerformance-based Restricted Stock Units · Derivative | 13,983 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013009 · doc4.xml · derivative · entry 4 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,830 Underlying: Common Stock · 13,983 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Based on the Company performance during the three-year performance period ending December 31, 2022, approximately 78.5% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). F1 · derivative.expiration_date: Based on the Company performance during the three-year performance period ending December 31, 2022, approximately 78.5% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:06 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Tax withholdingCommon Stock | 13,351 | $24.25 | $323,761.75 |
DisclosureSEC source: 0001209191-23-013009 · doc4.xml · nonDerivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,365 F3 · shares: These shares are being withheld to cover taxes related to the vesting of restricted stock units. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:06 UTC | BENCHMARK ELECTRONICS INC BHE · Entity 4343 | Exercise / conversionCommon Stock | 14,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013009 · doc4.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Based on the Company performance during the two-year performance period ending December 31, 2022, approximately 166.7% of the performance-based restricted stock units vested (as previously disclosed the reporting person had the opportunity to earn up to 250% of the number originally reported). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.